Prot #LOXO-BTK-18001: A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin's Lymphoma (NHL)
- Ma, Shuo (PD/PI)
Project: Research project
Project: Research project